In the total, stromal and tumor regions, the degree of infiltration of CD8+ T cell, CD68+ TAMs, and PD-L1+ cells were higher in the response [R, response to immunotherapy, including complete response (CR) and partial response (PR)] subgroup than in the nonresponse [NR, nonresponse to immunotherapy, including stable disease (SD) and progressive disease (PD)] subgroup. The gene discussed is CD8A; the disease is neoplasm.